Applications of artificial intelligence (AI) in drug discovery have attracted high interest in recent years, but evidence for clinically relevant impact so far is limited. This Perspective discusses p...

Here the authors combine a deep generative model with structure-based drug design and prospectively validate functionally active, nanomolar, A2A adenosine receptor ligands and solve their crystal stru...

Connect with 400+ pharma companies and 150+ global experts at the largest pharma conference in the region. Explore the latest innovations in API, drug manufacturing, and more in Riyadh, Saudi Arabia.